COL18A1 and pulmonary fibrosis: In a rat model of pulmonary fibrosis, inhibition of the VEGF/VEGFR pathway with the angiogenesis inhibitor endostatin has been demonstrated to ameliorate pulmonary fibrogenesis (Wan et al., 2013).